{
  "text": "Itraconazole therapy in aspergillosis: study in 49 patients.\n Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21).\n Itraconazole was prescribed alone or in combination or after treatment with amphotericin B and flucytosine.\n Of 14 aspergilloma patients, 2 were cured and 8 had symptomatic improvement.\n In chronic necrotizing pulmonary aspergillosis, 7 of 14 patients were cured and 6 improved significantly.\n In invasive aspergillosis treatment failed in 6 patients and 15 were cured.\n Itraconazole can be an alternative to amphotericin B in the treatment of invasive aspergillosis and chronic necrotizing pulmonary aspergillosis.\n In aspergilloma itraconazole may be useful in inoperable cases.",
  "category": "C08"
}